CYP1A1 and neoplasm: In addition, Zhou et al. [33] suggested that gene polymorphisms of CYP1A1 improved the accuracy of prognosis in metastatic breast cancer, demonstrating the predictive potential of CYP1A1 for tumor therapy and prognosis.